Ireland’s corporation tax revenue is increasingly concentrated in the hands of a few major multinationals, with three companies now accounting for nearly half of all receipts. According to a recent analysis by the Irish Fiscal Advisory Council (IFAC), these three firms paid approximately €13 billion, or 46%, of the total corporation tax collected in 2024. This growing reliance on a small number of corporations raises concerns about the sustainability of Ireland’s tax base and its vulnerability to shifts in the global economy.
Whereas IFAC has not officially named the companies, they are widely understood to be Apple, Microsoft, and pharmaceutical giant Eli Lilly. This concentration of tax revenue underscores the significant role these businesses play in the Irish economy, but also highlights the potential risks associated with such dependence. The trend of increasing corporation tax revenue has been particularly pronounced in recent years, nearly doubling between 2021 and 2024, even when excluding one-off payments from Apple related to past tax disputes.
The Tech Sector’s Dominance
The two technology companies, Apple and Microsoft, are estimated to have contributed almost 40% of Ireland’s total corporation tax receipts. This substantial contribution is driven by the profitability of both companies and their strategic presence in Ireland. Apple, in particular, has a long-standing history in the country, and Microsoft has significantly expanded its operations there in recent years. Both are poised to continue benefiting from global trends, including the ongoing advancements in artificial intelligence and increasing demand for their products and services.
The surge in demand for AI-related technologies is expected to further boost profits for both Apple and Microsoft. Apple’s continued innovation in consumer electronics and software, coupled with Microsoft’s dominance in cloud computing and enterprise software, positions them for sustained growth. This, in turn, is likely to translate into higher tax revenues for the Irish government, at least in the short to medium term.
Eli Lilly’s Rising Contribution
Beyond the tech giants, Eli Lilly is emerging as a significant contributor to Ireland’s corporation tax base. The pharmaceutical company is experiencing a surge in demand for its weight-loss and diabetes medications, particularly its GLP-1 agonists like tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for weight loss. In the third quarter of 2025, tirzepatide became the world’s best-selling drug, surpassing Merck’s Keytruda according to the Motley Fool.
This increased demand is directly impacting Eli Lilly’s financial performance and, its tax payments in Ireland. The company’s market capitalization recently touched $1 trillion, and analysts predict further growth as new applications for GLP-1 drugs emerge. The Motley Fool predicts Eli Lilly could become the next company to exceed a $2 trillion market cap by 2028.
Reliance and Uncertainty
Brian Cronin, an economist with the Irish Fiscal Advisory Council, emphasized the growing reliance on these three companies. He stated that the research “highlights how reliant Ireland’s corporation tax has become on just three companies.” This concentration creates a vulnerability, as the profits and tax payments of these firms are subject to significant uncertainty. Changes in global economic conditions, shifts in tax policies, or company-specific challenges could all have a substantial impact on Ireland’s tax revenue.
IFAC’s analysis suggests that while these companies are currently performing strongly, their future performance is not guaranteed. Factors such as increased competition, regulatory changes, and evolving consumer preferences could all affect their profitability and tax contributions. Ireland’s corporation tax receipts could be significantly higher or lower than current levels in the medium term.
The Irish government faces the challenge of balancing the benefits of attracting large multinational corporations with the need to diversify its tax base and reduce its reliance on a small number of players. Finding a sustainable path forward will require careful planning and a proactive approach to tax policy.
The next key update on Ireland’s corporation tax receipts is expected in the spring of 2026, when IFAC releases its annual report. This report will provide a more detailed assessment of the trends and risks facing the Irish tax system.
What are your thoughts on Ireland’s reliance on a few large corporations for tax revenue? Share your comments below, and please share this article with your network.
